| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.048 | 0.8 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.046 | 0.8 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |